Non-steroidal anti-inflammatory drugs are not fully safe for fetus: Comments on the article Treating common ear problems in pregnancy: What is safe? by Vlastarakos et al.

European Archives of Oto-Rhino-Laryngology

Volumn 265, Issue 5, 2008, Pages 609-611

  Burdan, Franciszek ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

DRUG SAFETY; FETUS DEATH; GASTROSCHISIS; HEART SEPTUM DEFECT; HUMAN; LETTER; PATENT DUCTUS ARTERIOSUS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; EAR DISEASES; FEMALE; FETUS; HUMANS; OTORHINOLARYNGOLOGIC DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 43349104029     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-008-0600-5     Document Type: Letter

References (18)

1. Vlastarakos PV, Nikolopoulos TP, Manolopoulos L, Ferekidis E, Kreatsas G (2008) Treating common ear problems in pregnancy: what is safe? Eur Arch Otorhinolaryngol 265(2):139-145. doi: 10.1007/s00405-007-0534-3
2. Ericson A, Källén BA (2001) Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 15(4):371-375
3. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8(3):209-228
4. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G (2002) Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 187(6):1623-1630
5. Ofori B, Oraichi D, Blais L, Rey E, Bérard A (2006) Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol 77(4):268-279
6. Martínez-Frías ML, Rodríguez-Pinilla E, Prieto L (1997) Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 56(4):241-243
7. Cook JC, Jacobson CF, Gao F, Tassinari MS, Hurtt ME, DeSesso JM (2003) Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Birth Defects Res B Dev Reprod Toxicol 68(1):5-26
8. Burdan F, Szumilo J, Dudka J, Korobowicz A, Klepacz R (2006) Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors. Pharmacol Res 53(3):287-292
9. Burdan F, Szumilo J, Dudka J, Korobowicz A, Klepacz R (2006) Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors. Braz J Med Biol Res 39(7):925-934
10. Kalter H (2003) Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established. Neurotoxicol Teratol 25(2):131-282
11. Nielsen GL, Sørensen HT, Larsen H, Pedersen L (2001) Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 322(7281):266-270
12. Li DK, Liu L, Odouli R (2003) Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 327(7411):368-373
13. Shaw GM, Todoroff K, Velie EM, Lammer EJ (1998) Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 57(1):1-7
14. Li Z, Ren A, Liu J, Pei L, Zhang L, Guo Z, Li Z (2007) Maternal flu or fever, medication use, and neural tube defects: a population-based case-control study in Northern China. Birth Defects Res A Clin Mol Teratol 79(4):295-300
15. Abe K, Honein MA, Moore CA (2003) Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies. Birth Defects Res A Clin Mol Teratol 67(11):911-918
16. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61(8):774-780
17. Sørensen HJ, Mortensen EL, Reinisch JM, Mednick SA (2004) Association between prenatal exposure to analgesics and risk of schizophrenia. Br J Psychiatry 185:366-371
18. Scialli AR, Buelke-Sam JL, Chambers CD, Friedman JM, Kimmel CA, Polifka JE, Tassinari MS (2004) Communicating risks during pregnancy: a workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs. Birth Defects Res A Clin Mol Teratol 70(1):7-12